Zenopharm

    OverviewSuggest Edit

    Zenopharm is a pharmaceutical company developing therapeutic solutions for the treatment of breast cancer. It offers ZB716, an oral selective estrogen receptor degrader (SERD), designed for breast cancer patients with metastatic disease.
    TypePrivate
    Founded2012
    Websitezenopharm.com

    Zenopharm Financials and Metrics

    Summary Metrics

    Founding Date

    2012
    Show all financial metrics

    Zenopharm Online and Social Media Presence

    Embed Graph

    Zenopharm Frequently Asked Questions

    • When was Zenopharm founded?

      Zenopharm was founded in 2012.

    • Who are Zenopharm competitors?

      Competitors of Zenopharm include Sermonix Pharmaceuticals, Briacell and Besins Healthcare.